title: Piliation of invasive Streptococcus pneumoniae isolates in the era before pneumococcal conjugate vaccine introduction in Malawi.
abstract: The pneumococcal pilus has been shown to be an important determinant of adhesion and virulence in mouse models of colonization, pneumonia, and bacteremia. A pilus is capable of inducing protective immunity, supporting its inclusion in next-generation pneumococcal protein vaccine formulations. Whether this vaccine target is common among pneumococci in sub-Saharan Africa is uncertain. To define the prevalence and genetic diversity of type I and II pili among invasive pneumococci in Malawi prior to the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) into routine childhood immunization, we examined 188 Streptococcus pneumoniae isolates collected between 2002 and 2008 (17% serotype 1). In this region of high disease burden, we found a low frequency of invasive piliated pneumococci (14%) and pilus gene sequence diversity similar to that seen previously in multiple global pneumococcal lineages. All common serotypes with pilus were covered by PCV13 and so we predict that pilus prevalence will be reduced in the Malawian pneumococcal population after PCV13 introduction.
authors.affiliation: The Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
authors.forename: Benard W
authors.initials: BW
authors.lastname: Kulohoma
authors.forename: Katherine
authors.initials: K
authors.lastname: Gray
authors.forename: Arox
authors.initials: A
authors.lastname: Kamng'ona
authors.forename: Jennifer
authors.initials: J
authors.lastname: Cornick
authors.forename: Stephen D
authors.initials: SD
authors.lastname: Bentley
authors.forename: Robert S
authors.initials: RS
authors.lastname: Heyderman
authors.forename: Dean B
authors.initials: DB
authors.lastname: Everett
mesh_terms: D000328:Adult; D000818:Animals; D002648:Child; D002675:Child, Preschool; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D010861:Fimbriae, Bacterial / Q000235:genetics*; D014644:Genetic Variation; D006801:Humans; D008295:Malawi / Q000453:epidemiology; D051379:Mice; D008969:Molecular Sequence Data; D022242:Pneumococcal Vaccines / Q000276:immunology; D017422:Sequence Analysis, DNA; D012703:Serotyping; D013290:Streptococcal Infections / Q000453:epidemiology / Q000382:microbiology*; D013296:Streptococcus pneumoniae / Q000235:genetics* / Q000302:isolation & purification
chemical_list: C538862:13-valent pneumococcal vaccine; D004269:DNA, Bacterial; D022242:Pneumococcal Vaccines
references.citation: Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W728-33
references.pmid: 15980573
references.citation: Clin Microbiol Infect. 2010 Sep;16(9):1501-4
references.pmid: 19886901
references.citation: Bioinformatics. 2007 Mar 15;23(6):673-9
references.pmid: 17237039
references.citation: Bioinformatics. 2009 Aug 1;25(15):1968-9
references.pmid: 19497936
references.citation: Science. 2005 Jul 1;309(5731):105
references.pmid: 15994549
references.citation: Bioinformatics. 2010 Mar 1;26(5):589-95
references.pmid: 20080505
references.citation: BMC Microbiol. 2008 Feb 28;8:41
references.pmid: 18307767
references.citation: PLoS One. 2011 Mar 15;6(3):e17765
references.pmid: 21423577
references.citation: Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5145-50
references.pmid: 17360408
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2857-62
references.pmid: 16481624
references.citation: Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12907-12
references.pmid: 17644611
references.citation: Genome Res. 2003 Sep;13(9):2178-89
references.pmid: 12952885
references.citation: N Engl J Med. 2003 May 1;348(18):1737-46
references.pmid: 12724479
references.citation: Immunology. 2012 Feb;135(2):125-32
references.pmid: 22044389
references.citation: Microbiol Mol Biol Rev. 2001 Jun;65(2):187-207 ; first page, table of contents
references.pmid: 11381099
references.citation: PLoS One. 2012;7(9):e44250
references.pmid: 22970189
references.citation: Emerg Infect Dis. 2010 Jun;16(6):955-62
references.pmid: 20507746
references.citation: N Engl J Med. 2010 Mar 4;362(9):812-22
references.pmid: 20200385
references.citation: Lancet Infect Dis. 2004 Mar;4(3):144-54
references.pmid: 14998500
references.citation: J Infect Dis. 2008 Mar 15;197(6):888-96
references.pmid: 18269316
references.citation: Infect Immun. 2007 Feb;75(2):1059-62
references.pmid: 17145945
references.citation: Nat Rev Microbiol. 2006 Jul;4(7):509-19
references.pmid: 16778837
references.citation: Lancet. 2009 Sep 12;374(9693):893-902
references.pmid: 19748398
references.citation: Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15641-6
references.pmid: 16223875
references.citation: PLoS One. 2011;6(9):e25610
references.pmid: 21980502
references.citation: J Exp Med. 1987 Apr 1;165(4):1016-25
references.pmid: 2435829
references.citation: Genome Res. 2008 May;18(5):821-9
references.pmid: 18349386
references.citation: Vaccine. 2010 Jul 5;28(30):4842-6
references.pmid: 20434550
references.citation: Syst Biol. 2003 Oct;52(5):696-704
references.pmid: 14530136
references.citation: J Bacteriol. 2008 Aug;190(15):5480-92
references.pmid: 18515415
references.citation: Clin Infect Dis. 2009 Mar 15;48(6):760-3
references.pmid: 19207082
references.citation: J Clin Microbiol. 2007 Jun;45(6):1684-9
references.pmid: 17392439
references.citation: Bioinformatics. 2010 Jul 15;26(14):1704-7
references.pmid: 20562415
references.citation: Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
references.pmid: 15034147
references.citation: Science. 2011 Jan 28;331(6016):430-4
references.pmid: 21273480
references.citation: Trends Microbiol. 2004 May;12(5):228-34
references.pmid: 15120142